Drug Designing and Biomarkers

biomarker is an attribute that can be studied as an indicator of pathogenic and biological operation along with pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity in the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

  • Drug designing is an inventive process to find new medication centred on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions
  • Adrenergic receptor
  • Protein crystallography
  • Scoring functions

Related Conference of Drug Designing and Biomarkers

September 22-23, 2020

International Conference on Nucleic Acids

Dubai, UAE
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
September 29-30, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
October 21-22, 2020

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 07-08, 2020

9th World Congress on Glycobiology & Glycochemistry

Dubai, UAE
December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 18-19, 2021

12th Tissue Repair and Regeneration Congress

Abu Dhabi, UAE
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic

Drug Designing and Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in